These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30552336)

  • 1. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.
    Croft B; Ohnesorg T; Hewitt J; Bowles J; Quinn A; Tan J; Corbin V; Pelosi E; van den Bergen J; Sreenivasan R; Knarston I; Robevska G; Vu DC; Hutson J; Harley V; Ayers K; Koopman P; Sinclair A
    Nat Commun; 2018 Dec; 9(1):5319. PubMed ID: 30552336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development.
    Benko S; Gordon CT; Mallet D; Sreenivasan R; Thauvin-Robinet C; Brendehaug A; Thomas S; Bruland O; David M; Nicolino M; Labalme A; Sanlaville D; Callier P; Malan V; Huet F; Molven A; Dijoud F; Munnich A; Faivre L; Amiel J; Harley V; Houge G; Morel Y; Lyonnet S
    J Med Genet; 2011 Dec; 48(12):825-30. PubMed ID: 22051515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development.
    Kim GJ; Sock E; Buchberger A; Just W; Denzer F; Hoepffner W; German J; Cole T; Mann J; Seguin JH; Zipf W; Costigan C; Schmiady H; Rostásy M; Kramer M; Kaltenbach S; Rösler B; Georg I; Troppmann E; Teichmann AC; Salfelder A; Widholz SA; Wieacker P; Hiort O; Camerino G; Radi O; Wegner M; Arnold HH; Scherer G
    J Med Genet; 2015 Apr; 52(4):240-7. PubMed ID: 25604083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Duplication Upstream of SOX9 Associated with
    Mengen E; Kayhan G; Kocaay P; Uçaktürk SA
    J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):308-314. PubMed ID: 31476840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal Identity in the Absence of Pro-Testis Factor SOX9 and Pro-Ovary Factor Beta-Catenin in Mice.
    Nicol B; Yao HH
    Biol Reprod; 2015 Aug; 93(2):35. PubMed ID: 26108792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the regulatory region upstream of SOX9 associated with 46,XX testicular disorders of Sex Development (DSD).
    Hyon C; Chantot-Bastaraud S; Harbuz R; Bhouri R; Perrot N; Peycelon M; Sibony M; Rojo S; Piguel X; Bilan F; Gilbert-Dussardier B; Kitzis A; McElreavey K; Siffroi JP; Bashamboo A
    Am J Med Genet A; 2015 Aug; 167A(8):1851-8. PubMed ID: 25900885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations.
    Knower KC; Kelly S; Ludbrook LM; Bagheri-Fam S; Sim H; Bernard P; Sekido R; Lovell-Badge R; Harley VR
    PLoS One; 2011 Mar; 6(3):e17751. PubMed ID: 21412441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
    Ludbrook LM; Bernard P; Bagheri-Fam S; Ryan J; Sekido R; Wilhelm D; Lovell-Badge R; Harley VR
    Endocrinology; 2012 Apr; 153(4):1948-58. PubMed ID: 22294746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of Sox9 expression in the gonad.
    Gonen N; Lovell-Badge R
    Curr Top Dev Biol; 2019; 134():223-252. PubMed ID: 30999977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XY Sox9 embryonic loss-of-function mouse mutants show complete sex reversal and produce partially fertile XY oocytes.
    Lavery R; Lardenois A; Ranc-Jianmotamedi F; Pauper E; Gregoire EP; Vigier C; Moreilhon C; Primig M; Chaboissier MC
    Dev Biol; 2011 Jun; 354(1):111-22. PubMed ID: 21466799
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dujardin E; André M; Dewaele A; Mandon-Pépin B; Poulat F; Frambourg A; Thépot D; Jouneau L; Jolivet G; Pailhoux E; Pannetier M
    Elife; 2023 Oct; 12():. PubMed ID: 37847154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered SOX9 genital tubercle enhancer region in hypospadias.
    Sreenivasan R; Gordon CT; Benko S; de Iongh R; Bagheri-Fam S; Lyonnet S; Harley V
    J Steroid Biochem Mol Biol; 2017 Jun; 170():28-38. PubMed ID: 27989796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRY upregulation of SOX9 is inefficient and delayed, allowing ovarian differentiation, in the B6.Y(TIR) gonad.
    Park S; Zeidan K; Shin JS; Taketo T
    Differentiation; 2011 Jul; 82(1):18-27. PubMed ID: 21592645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended pedigree with multiple cases of XX sex reversal in the absence of SRY and of a mutation at the SOX9 locus.
    Temel SG; Gulten T; Yakut T; Saglam H; Kilic N; Bausch E; Jin WJ; Leipoldt M; Scherer G
    Sex Dev; 2007; 1(1):24-34. PubMed ID: 18391513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a New Enhancer That Promotes Sox9 Expression by a Comparative Analysis of Mouse and Sry-Deficient Amami Spiny Rat.
    Hirata Y; Mizushima S; Mitsukawa S; Kon M; Kuroki Y; Jogahara T; Shinohara N; Kuroiwa A
    Cytogenet Genome Res; 2023; 163(5-6):307-316. PubMed ID: 38246151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the first promoter-specific gain-of-function SOX9 missense variant (p.E50K) in a patient with 46,XX ovotesticular disorder of sex development.
    Ushijima K; Ogawa Y; Terao M; Asakura Y; Muroya K; Hayashi M; Ishii T; Hasegawa T; Sekido R; Fukami M; Takada S; Narumi S
    Am J Med Genet A; 2021 Apr; 185(4):1067-1075. PubMed ID: 33399274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.
    Sreenivasan R; Ludbrook L; Fisher B; Declosmenil F; Knower KC; Croft B; Bird AD; Ryan J; Bashamboo A; Sinclair AH; Koopman P; McElreavey K; Poulat F; Harley VR
    Hum Mutat; 2018 Dec; 39(12):1861-1874. PubMed ID: 30067310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3.
    Vetro A; Dehghani MR; Kraoua L; Giorda R; Beri S; Cardarelli L; Merico M; Manolakos E; Parada-Bustamante A; Castro A; Radi O; Camerino G; Brusco A; Sabaghian M; Sofocleous C; Forzano F; Palumbo P; Palumbo O; Calvano S; Zelante L; Grammatico P; Giglio S; Basly M; Chaabouni M; Carella M; Russo G; Bonaglia MC; Zuffardi O
    Eur J Hum Genet; 2015 Aug; 23(8):1025-32. PubMed ID: 25351776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone.
    Gonen N; Quinn A; O'Neill HC; Koopman P; Lovell-Badge R
    PLoS Genet; 2017 Jan; 13(1):e1006520. PubMed ID: 28045957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex reversal following deletion of a single distal enhancer of
    Gonen N; Futtner CR; Wood S; Garcia-Moreno SA; Salamone IM; Samson SC; Sekido R; Poulat F; Maatouk DM; Lovell-Badge R
    Science; 2018 Jun; 360(6396):1469-1473. PubMed ID: 29903884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.